propranolol and Cretinism studies

propranolol and Cretinism

propranolol has been researched along with Cretinism in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

Excerpt	Relevance	Reference
"Consumptive hypothyroidism is a rare condition related to massive infantile hemangiomas producing an excess of the thyroid-hormone-inactivating enzyme type 3 iodothyronine deiodinase."	1.38	Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. ( Chiumello, G; Cortinovis, F; Di Frenna, M; Gelmetti, C; Passoni, A; Persani, L; Rabbiosi, S; Vigone, MC; Weber, G, 2012)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Avagyan, S	1
Klein, M	1
Kerkar, N	1
Demattia, A	1
Blei, F	1
Lee, S	1
Rosenberg, HK	1
Arnon, R	1
Vigone, MC	1
Cortinovis, F	1
Rabbiosi, S	1
Di Frenna, M	1
Passoni, A	1
Persani, L	1
Chiumello, G	1
Gelmetti, C	1
Weber, G	1

Studies

Avagyan, S

Klein, M

Kerkar, N

Demattia, A

Blei, F

Lee, S

Rosenberg, HK

Arnon, R

Vigone, MC

Cortinovis, F

Rabbiosi, S

Di Frenna, M

Passoni, A

Persani, L

Chiumello, G

Gelmetti, C

Weber, G

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Sirolimus in the Treatment for Propranolol-resistant Infantile Hepatic Hemangioendothelioma[NCT04406870]	Phase 4	36 participants (Anticipated)	Interventional	2020-07-31	Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Sirolimus in the Treatment for Propranolol-resistant Infantile Hepatic Hemangioendothelioma[NCT04406870]

Phase 4

36 participants (Anticipated)

Interventional

2020-07-31

Not yet recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for propranolol and Cretinism

Article	Year
Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma. Journal of pediatric gastroenterology and nutrition, 2013, Volume: 56, Issue:3 Topics: Adrenergic beta-2 Receptor Antagonists; Antineoplastic Agents; Congenital Hypothyroidism; Drug Monit	2013
Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. Journal of pediatric endocrinology & metabolism : JPEM, 2012, Volume: 25, Issue:1-2 Topics: Adrenal Cortex Hormones; Congenital Hypothyroidism; Female; Hemangioma; Humans; Hypothyroidism; Infa	2012

Article

Year

Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma.

Journal of pediatric gastroenterology and nutrition, 2013, Volume: 56, Issue:3

Topics: Adrenergic beta-2 Receptor Antagonists; Antineoplastic Agents; Congenital Hypothyroidism; Drug Monit

2013

Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma.

Journal of pediatric endocrinology & metabolism : JPEM, 2012, Volume: 25, Issue:1-2

Topics: Adrenal Cortex Hormones; Congenital Hypothyroidism; Female; Hemangioma; Humans; Hypothyroidism; Infa

2012